Follicle and oocyte developmental dynamics

Biology and Pathology of the Oocyte: Role in Fertility, Medicine, and Nuclear Reprogramming, Second Edition

Volumn , Issue , 2012, Pages 62-72

  Hsueh, Aaron J W ^a   Kawamura, Kazuhiro ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84928079757     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139135030.007     Document Type: Chapter

References (57)

1. McGee EA, Hsueh AJ. Initial and cyclic recruitment of ovarian follicles. Endocr Rev 2000; 21(2): 200–14.
2. Macklon NS, Fauser BC. Aspects of ovarian follicle development throughout life. Horm Res 1999; 52(4): 161–70.
3. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev 1996; 17(2): 121–55.
4. Hsueh AJ, Billig H, Tsafriri A. Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 1994; 15(6): 707–24.
5. Zeleznik AJ. Follicle selection in primates: “many are called but few are chosen”. Biol Reprod 2001; 65(3): 655–9.
6. Telfer EE, Gosden RG, Byskov AG, et al. On regenerating the ovary and generating controversy. Cell 2005; 122(6): 821–2.
7. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004; 428(6979): 145–50.
8. Skaznik-Wikiel M, Lee HJ, Tschudy KS, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 2005; 122: 303–15.
9. Eggan K, Jurga S, Gosden R, Min IM, Wagers AJ. Ovulated oocytes in adult mice derive from non-circulating germ cells. Nature 2006; 441(7097): 1109–14.
10. Zhang H, Zheng W, Shen Y, et al. Experimental evidence showing that no mitotically active female germline progenitors exist in postnatal mouse ovaries. Proc Natl Acad Sci USA 2012; 109(31): 12580–5.
11. Blandau R, Warrick E, Rumery RE. In vitro cultivation of fetal mouse ovaries. Fertil Steril 1965; 16(6): 705–15.
12. Skinner MK. Regulation of primordial follicle assembly and development.HumReprod Update 2005; 11(5): 461–71.
13. Carlsson IB, Laitinen MP, Scott JE, et al. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture. Reproduction 2006; 131(4): 641–9.
14. Hutt KJ, McLaughlin EA, Holland MK. KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth. Biol Reprod 2006; 75(3): 421–33.
15. Parrott JA, Skinner MK. Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 1999; 140(9): 4262–71.
16. Nilsson EE, Detzel C, Skinner MK. Platelet-derived growth factor modulates the primordial to primary follicle transition. Reproduction 2006; 131(6): 1007–15. Epub 2006/06/01.
17. Ojeda SR, Romero C, Tapia V, Dissen GA. Neurotrophic and cell-cell dependent control of early follicular development. Mol Cell Endocrinol 2000; 163(1–2): 67–71.
18. Roberts AE, Arbogast LK, Friedman CI, et al. Neutralization of endogenous vascular endothelial growth factor depletes primordial follicles in the mouse ovary. Biol Reprod 2007; 76(2): 218–23.
19. Tanwar PS, O’Shea T, McFarlane JR. In vivo evidence of role of bone morphogenetic protein-4 in the mouse ovary. Anim Reprod Sci 2008; 106(3–4): 232–40.
20. Lee WS, Otsuka F, Moore RK, Shimasaki S. Efect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 2001; 65(4): 994–9.
21. Kezele P, Nilsson EE, Skinner MK. Keratinocyte growth factor acts as a mesenchymal factor that promotes ovarian primordial to primary follicle transition. Biol Reprod 2005; 73(5): 967–73.
22. Reddy P, Shen L, Ren C, et al. Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol 2005; 281(2): 160–70.
23. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003; 301(5630): 215–18.
24. Reddy P, Liu L, Adhikari D, et al. Oocyte-speciic deletion of Pten causes premature activation of the primordial follicle pool. Science 2008; 319(5863): 611–13.
25. John GB, Gallardo TD, Shirley LJ, Castrillon DH. Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol 2008; 321(1): 197–204.
26. Posner BI, Faure R, Burgess JW, et al. Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 1994; 269(6): 4596–604.
27. Rosivatz E, Matthews JG, McDonald NQ, et al. A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN). ACS Chem Biol 2006; 1(12): 780–90.
28. Derossi D, Williams EJ, Green PJ, Dunican DJ, Doherty P. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem Biophys Res Commun 1998; 251(1): 148–52.
29. Li J, Kawamura K, Cheng Y, et al. Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci USA 2010; 107(22): 10280–4. Epub 2010/05/19.
30. White SS, Ojeda SR. Changes in ovarian luteinizing hormone and follicle-stimulating hormone receptor content and in gonadotropin-induced ornithine decarboxylase activity during prepubertal and pubertal development of the female rat. Endocrinology 1981; 109(1): 152–61.
31. O’Shaughnessy PJ, McLelland D, McBride MW. Regulation of luteinizing hormone-receptor and follicle-stimulating hormone-receptor messenger ribonucleic acid levels during development in the neonatal mouse ovary. Biol Reprod 1997; 57(3): 602–8.
32. Dong J, Albertini DF, Nishimori K, et al. Growth diferentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383(6600): 531–5.
33. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth diferentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced diferentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod 2000; 62(2): 370–7.
34. Vitt UA, McGee EA, Hayashi M, Hsueh AJ. In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology 2000; 141(10): 3814–20.
35. Orisaka M, Orisaka S, Jiang JY, et al. Growth diferentiation factor 9 is antiapoptotic during follicular development from preantral to early antral stage.Mol Endocrinol 2006; 20(10): 2456–68. Epub 2006/06/03.
36. Otsuka F, Yao Z, Lee T, et al. Bone morphogenetic protein-15. Identiication of target cells and biological functions. J Biol Chem 2000; 275(50): 39523–8. Epub 2000/09/22.
37. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000; 25(3): 279–83. Epub 2000/07/11.
38. Yan C, Wang P, DeMayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth diferentiation factor 9 in ovarian function. Mol Endocrinol 2001; 15(6): 854–66. Epub 2001/05/29.
39. Davis GH, McEwan JC, Fennessy PF, et al. Infertility due to bilateral ovarian hypoplasia in sheep homozygous (FecXI FecXI) for the Inverdale proliicacy gene located on the X chromosome. Biol Reprod 1992; 46(4): 636–40. Epub 1992/04/01.
40. Hanrahan JP, Gregan SM, Mulsant P, et al. Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 2004; 70(4): 900–9. Epub 2003/11/25.
41. Ebeling S, Topfer D, Weitzel JM, Meinecke B. Bone morphogenetic protein-6 (BMP-6): mRNA expression and efect on steroidogenesis during in vitro maturation of porcine cumulus oocyte complexes. Reprod Fertil Dev 2012; 23(8): 1034–42. Epub 2011/12/01.
42. Eppig JJ. Coordination of nuclear and cytoplasmic oocyte maturation in eutherian mammals. Reprod Fertil Dev 1996; 8(4): 485–9. Epub 1996/01/01.
43. Tsafriri A, Pomerantz SH. Oocyte maturation inhibitor. Clin Endocrinol Metab 1986; 15(1): 157–70. Epub 1986/02/01.
44. Zhang M, Su YQ, Sugiura K, Xia G, Eppig JJ. Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science 2010; 330(6002): 366–9. Epub 2010/10/16.
45. Kawamura K, Cheng Y, Kawamura N, et al. Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes. Hum Reprod 2011; 26(11): 3094–101. Epub 2011/08/26.
46. Sato Y, Cheng Y, Kawamura K, Takae S, Hsueh AJ. C-type natriuretic peptide stimulates ovarian follicle development. Mol Endocrinol 2012; 26(7): 1158–66.
47. McGee EA, Perlas E, LaPolt PS, Tsafriri A, Hsueh AJ. Follicle-stimulating hormone enhances the development of preantral follicles in juvenile rats. Biol Reprod 1997; 57(5): 990–8.
48. Jones KT. Meiosis in oocytes: predisposition to aneuploidy and its increased incidence with age. Hum Reprod Update 2008; 14(2): 143–58. Epub 2007/12/18.
49. Rienzi L, Martinez F, Ubaldi F, et al. Polscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod 2004; 19(3): 655–9. Epub 2004/03/05.
50. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet 2004; 75(1): 106–11. Epub 2004/05/12.
51. Dixit H, Rao LK, Padmalatha VV, et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006; 119(4): 408–15. Epub 2006/03/02.
52. Tiotiu D, Alvaro Mercadal B, Imbert R, et al. Variants of the BMP15 gene in a cohort of patients with premature ovarian failure. Hum Reprod 2010; 25(6): 1581–7. Epub 2010/04/07.
53. Laissue P, Christin-Maitre S, Touraine P, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006; 154(5): 739–44. Epub 2006/04/29.
54. Palmer JS, Zhao ZZ, Hoekstra C, et al. Novel variants in growth diferentiation factor 9 in mothers of dizygotic twins. J Clin Endocrinol Metab 2006; 91(11): 4713–16. Epub 2006/09/07.
55. Hanevik HI, Hilmarsen HT, Skjelbred CF, Tanbo T, Kahn JA. A single nucleotide polymorphism in BMP15 is associated with high response to ovarian stimulation. Reprod Biomed Online 2011; 23(1): 97–104. Epub 2011/05/14.
56. Pal L, Santoro N. Premature ovarian failure (POF): discordance between somatic and reproductive aging. Ageing Res Rev 2002; 1(3): 413–23.
57. Donnez J, Silber S, Andersen CY, et al. Children born ater autotransplantation of cryopreserved ovarian tissue: a review of 13 live births. Ann Med 2011; 43(6): 437–50. Epub 2011/01/14.